TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7887548

Group type: EXPERIMENTAL
Intervention: Intensive therapy with three or more daily insulin injections or continuous subcutaneous insulin infusion guided by four or more glucose tests per day
Number of subjects: 1441

Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Conventional therapy with one or two daily insulin injections
Number of subjects: 1441
Study: 2223115

Group type: EXPERIMENTAL
Intervention: Continuous extrapleural intercostal nerve block (CEINB) with 0.5% bupivacaine
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no CEINB)
Number of subjects: 46
Study: 358371

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus BCG
Number of subjects: 63

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 63
Study: 30951847

Group type: EXPERIMENTAL
Intervention: Kinesthetic motor imagery of left and right finger extension
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Brain-machine interface with passive hand opening by a robotic orthosis
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Motor imagery and proprioceptive feedback
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Neurofeedback
Number of subjects: 21
Study: 27890660

Group type: EXPERIMENTAL
Intervention: Expressive writing before biopsy
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Expressive writing after biopsy (completed within first 6 days)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Neutral writing before biopsy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Neutral writing after biopsy
Number of subjects: 122
Study: 26192813

Group type: EXPERIMENTAL
Intervention: Biodegradable fixation system (Inion CPS)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Titanium fixation system (KLS Martin)
Number of subjects: 230
Study: 24029029

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 30
Study: 20538475

Group type: EXPERIMENTAL
Intervention: Narrow gastric tube reconstruction (NGT group, n=52)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Whole stomach reconstruction (WS group, n=52)
Number of subjects: 104
Study: 19680634

Group type: EXPERIMENTAL
Intervention: MDMA (1.5 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: MDMA (0.75 mg/kg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 9
Study: 17898405

Group type: EXPERIMENTAL
Intervention: Superficial cervical plexus block
Number of subjects: 42

Group type: COMPARATOR
Intervention: Combined deep and superficial cervical plexus block
Number of subjects: 42
Study: 15209006

Group type: EXPERIMENTAL
Intervention: NaFeEDTA fortified soy sauce
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11684933

Group type: EXPERIMENTAL
Intervention: 6 months of isoniazid (INH)
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: 3 months of INH plus rifampicin (3HR)
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: 3 months of INH plus rifampicin and pyrazinamide (3HRZ)
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: Combination of rifampicin-containing regimens (3HR and 3HRZ)
Number of subjects: 2736

Group type: EXPERIMENTAL
Intervention: 6 months of isoniazid (INH) among anergic subjects
Number of subjects: 2736

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 2736
Study: 9041901

Group type: EXPERIMENTAL
Intervention: Postpolio group (N=121)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Postpolio syndrome (N not specified)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Age-matched controls (N=60)
Number of subjects: 181
Study: 8924310

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg/day)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 2350520

Group type: EXPERIMENTAL
Intervention: Rest (no exercise)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exercise at 42% of VO2, max
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exercise at 61% of VO2, max
Number of subjects: 6

Group type: COMPARATOR
Intervention: Exercise at 80% of VO2, max
Number of subjects: 6
Study: 386698

Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g/day for 6 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Gefarnate 250 mg/day for 6 weeks
Number of subjects: 30
Study: 31129617

Group type: EXPERIMENTAL
Intervention: Early activation of thoracic epidural anesthesia (EA TEA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Late activation of thoracic epidural anesthesia (LA TEA)
Number of subjects: 50
Study: 28614270

Group type: EXPERIMENTAL
Intervention: CTU group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 23543334

Group type: EXPERIMENTAL
Intervention: Strattice™
Number of subjects: 172

Group type: COMPARATOR
Intervention: Ultrapro
Number of subjects: 172
Study: 22573127

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil 10 mg (up-titrated to 20 and 40 mg)
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Ramipril 2.5 mg (up-titrated to 5 and 10 mg)
Number of subjects: 1453

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil
Number of subjects: 1453

Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 1453
Study: 20083382

Group type: EXPERIMENTAL
Intervention: Genuine acupuncture
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 18
Study: 18420368

Group type: EXPERIMENTAL
Intervention: Fludrocortisone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 12
Study: 15867334

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy and diet (n = 5)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Wait-list control (n = 4)
Number of subjects: 37

Group type: COMPARATOR
Intervention: BED subjects compared to nonbinge eating normals (NB)
Number of subjects: 37
Study: 14692469

Group type: EXPERIMENTAL
Intervention: zaleplon 10 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: zopiclone 7.5 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: temazepam 15 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: melatonin 6 mg
Number of subjects: 23

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study: 10791665

Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Compression plating (PLT)
Number of subjects: 84
Study: 8821299

Group type: EXPERIMENTAL
Intervention: HDM allergen measurement using monoclonal antibody enzyme linked immunosorbent assay (ELISA)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: HDM allergen measurement
Number of subjects: 215
Study: 2119555

Group type: EXPERIMENTAL
Intervention: Intravenous fibronectin (7.5 mg.kg‐1.d‐1 for 4 days)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 6988304

Group type: EXPERIMENTAL
Intervention: Prednisolone therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 44
Study: 30928884

Group type: EXPERIMENTAL
Intervention: MABT (Mindful Awareness in Body‐oriented Therapy)
Number of subjects: 187

Group type: COMPARATOR
Intervention: TAU (Treatment as Usual)
Number of subjects: 187

Group type: COMPARATOR
Intervention: WHE (Women's Health Education)
Number of subjects: 187
Study: 27627630

Group type: EXPERIMENTAL
Intervention: brief remoralization treatment
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: brief exposure treatment
Number of subjects: 78

Group type: COMPARATOR
Intervention: waiting list (WL)
Number of subjects: 78
Study: 25986854

Group type: EXPERIMENTAL
Intervention: Axillary lymph node dissection (ALND)
Number of subjects: 9521

Group type: COMPARATOR
Intervention: Sentinel lymph node biopsy alone (SLNB)
Number of subjects: 9521
Study: 23636445

Group type: EXPERIMENTAL
Intervention: WHO criteria for gestational diabetes mellitus (GDM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified IADPSG criteria for gestational diabetes mellitus (GDM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight gain in pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal weight loss post-partum
Number of subjects: 0
Study: 21247480

Group type: EXPERIMENTAL
Intervention: DNA analysis, family history of CD and smoking status
Number of subjects: 470

Group type: COMPARATOR
Intervention: Family history of CD and smoking status
Number of subjects: 470
Study: 19695525

Group type: EXPERIMENTAL
Intervention: Prehabilitation exercises (resistance training, flexibility, step training) 3 times per week before TKA
Number of subjects: 54

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 54
Study: 17944603

Group type: EXPERIMENTAL
Intervention: Various performance assessment methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-method strategy for performance assessment
Number of subjects: 0
Study: 15212867

Group type: EXPERIMENTAL
Intervention: Care co-ordination (CC) program involving care planning by a general practitioner (GP) and graduated case management.
Number of subjects: 2742

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 2742

Group type: EXPERIMENTAL
Intervention: Care co-ordination (CC) program
Number of subjects: 2742
Study: 11171680

Group type: EXPERIMENTAL
Intervention: Continued methotrexate treatment (group A)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Discontinued methotrexate treatment (group B)
Number of subjects: 388

Group type: COMPARATOR
Intervention: No methotrexate treatment (group C)
Number of subjects: 388
Study: 9764335

Group type: EXPERIMENTAL
Intervention: Artesunate with mefloquine (25 mg/kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Artesunate alone
Number of subjects: 100
Study: 8043556

Group type: EXPERIMENTAL
Intervention: Progestogens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prostaglandin synthetase inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antifibrinolytic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gonadotrophin-releasing hormone analogues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 0
Study: 3061354

Group type: EXPERIMENTAL
Intervention: Jelonet and Whitehead's varnish (compound iodoform paint BPC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard dressing of Jelonet, gauze, wool and a crêpe bandage
Number of subjects: 40
Study: 29267519

Group type: COMPARATOR
Intervention: 400mg Ibuprofen 60 min preemptive + 400mg Ibuprofen postoperative
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4mg Dexamethasone 60 min preemptive + 4mg Dexamethasone postoperative
Number of subjects: 20
Study: 26645254

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN, 5 mg/d for 7 days)
Number of subjects: 629

Group type: COMPARATOR
Intervention: No GTN (control)
Number of subjects: 629

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate (GTN) in patients randomized within 6 hours
Number of subjects: 629
Study: 25268838

Group type: EXPERIMENTAL
Intervention: n‐3 FA‐enriched oral nutritional supplement (ONS) providing 2.0 g of eicosapentaenoic acid (EPA) and 1.0 g of docosahexaenoic acid (DHA) per day
Number of subjects: 148

Group type: COMPARATOR
Intervention: standard ONS
Number of subjects: 148
Study: 23830725

Group type: EXPERIMENTAL
Intervention: Sunflower oil massage
Number of subjects: 54

Group type: COMPARATOR
Intervention: Body massage alone
Number of subjects: 54
Study: 20369615

Group type: EXPERIMENTAL
Intervention: Fosinopril with Propranolol
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Fosinopril with Cytomack
Number of subjects: 42
Study: 18972730

Group type: EXPERIMENTAL
Intervention: Small needle-knife comprehensive therapy
Number of subjects: 305

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 305
Study: 17010793

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 9978

Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 9978

Group type: EXPERIMENTAL
Intervention: No pretreatment
Number of subjects: 9978

Group type: EXPERIMENTAL
Intervention: Consistent therapy with enoxaparin
Number of subjects: 9978
Study: 14572425

Group type: EXPERIMENTAL
Intervention: Intervention (nutrition sessions and written materials)
Number of subjects: 1055

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 1055
Study: 11090807

Group type: EXPERIMENTAL
Intervention: Left ventricular pacing
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sinus rhythm or right ventricular pacing
Number of subjects: 13
Study: 8958418

Group type: COMPARATOR
Intervention: tissue plasminogen activator (t-PA)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: primary percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 395
Study: 1302750

Group type: EXPERIMENTAL
Intervention: Stimuliv (2 tablets thrice daily)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Stimuliv
Number of subjects: 145
Study: 3924553

Group type: EXPERIMENTAL
Intervention: acarbose (3 X 100 mg/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 9
Study: 31262265

Group type: EXPERIMENTAL
Intervention: Fascia iliaca block using 30 ml of bupivacaine 0.5% with epinephrine 1:200,000
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham injection with normal saline
Number of subjects: 30
Study: 30152645

Group type: EXPERIMENTAL
Intervention: VNS + TAU
Number of subjects: 599

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 599
Study: 26829251

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS/Candesartan combination therapy (N: 20, 30, or 60 mg; C: 4, 8, 16, or 32 mg daily)
Number of subjects: 1362

Group type: COMPARATOR
Intervention: Nifedipine monotherapy
Number of subjects: 1362

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1362

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS/Candesartan combination therapy
Number of subjects: 1362
Study: 24184617

Group type: EXPERIMENTAL
Intervention: Isometric stabilization exercises
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Isotonic stabilization exercises
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 39
Study: 22699818

Group type: EXPERIMENTAL
Intervention: L-thyroxine (L-T4) treatment for 24 months
Number of subjects: 161

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 161
Study: 20227168

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative pelvic floor muscle exercise (PFME)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Postoperative pelvic floor muscle exercise (PFME)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Preoperative PFME
Number of subjects: 118
Study: 17106274

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 237

Group type: COMPARATOR
Intervention: Stavudine
Number of subjects: 237
Study: 16323716

Group type: EXPERIMENTAL
Intervention: 188Re‐HEDP (3194 +/‐ 387 MBq)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 186Re‐HEDP (1358 +/‐ 158 MBq)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 89Sr (152 +/‐ 19 MBq)
Number of subjects: 64
Study: 11856082

Group type: EXPERIMENTAL
Intervention: 0.5 mg ridogrel once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2.5 mg ridogrel once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5.0 mg ridogrel once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5 mg ridogrel once daily (International trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2.5 mg ridogrel once daily (International trial)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5.0 mg ridogrel once daily (International trial)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mesalazine 800 mg three times daily (International trial)
Number of subjects: 0
Study: 9660334

Group type: EXPERIMENTAL
Intervention: Combination of anorganic bovine-derived hydroxyapatite matrix (ABM) and cell binding peptide (P-15)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Demineralized freeze-dried bone allograft (DFDBA)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Open flap debridement (DEBR)
Number of subjects: 31
Study: 8617528

Group type: EXPERIMENTAL
Intervention: Furazolidone (7.5 mg/kg/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Nalidixic acid (55 mg/kg/day)
Number of subjects: 72
Study: 2534412

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 29147854

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Loratadine
Number of subjects: 600

Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 600
Study: 28963303

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 64

Group type: COMPARATOR
Intervention: Dietary weight loss programme
Number of subjects: 64
Study: 26302784

Group type: EXPERIMENTAL
Intervention: 6‐h postoperative clamped suction tube drainage
Number of subjects: 44

Group type: COMPARATOR
Intervention: Non‐clamped suction tube drainage
Number of subjects: 44
Study: 23160977

Group type: EXPERIMENTAL
Intervention: 80 kVp protocol with 50% reduced contrast (185 mgI/kg)
Number of subjects: 68

Group type: COMPARATOR
Intervention: 120 kVp protocol with standard contrast (370 mgI/kg)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 80 kVp with hybrid-iterative reconstruction
Number of subjects: 68
Study: 20610085

Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05%
Number of subjects: 14

Group type: COMPARATOR
Intervention: Artificial tear
Number of subjects: 14
Study: 19100929

Group type: EXPERIMENTAL
Intervention: Triple airway (TA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Jaw thrust with teeth protrusion (JTP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Head tilt with chin lift (HT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Original airway position (OA)
Number of subjects: 40
Study: 16645545

Group type: EXPERIMENTAL
Intervention: 0.625 mg of conjugated equine estrogens (CEE) and 2.5 mg of medroxyprogesterone acetate (MPA) daily
Number of subjects: 73

Group type: COMPARATOR
Intervention: 0.625 mg of conjugated equine estrogens (CEE) and 2.5 mg of medroxyprogesterone acetate (MPA) on alternate days
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Both groups receiving HT
Number of subjects: 73
Study: 12818283

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 39

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 39
Study: 10958375

Group type: EXPERIMENTAL
Intervention: Creatine supplementation for 1 week in vegetarians (VC) and meat-eaters (MC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creatine supplementation in meat-eaters (MC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (glucose only, MG)
Number of subjects: 0
Study: 8851828

Group type: EXPERIMENTAL
Intervention: 2% isobaric mepivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.5% isobaric bupivacaine with adrenalin
Number of subjects: 90
Study: 1993037

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin therapy (325 mg on alternate days)
Number of subjects: 22071

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22071

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin therapy (325 mg on alternate days) among younger men (aged 40 to 59 years)
Number of subjects: 22071
Study: 6224001

Group type: EXPERIMENTAL
Intervention: 0.1% octenidine in vehicle
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.1% octenidine in aqueous solution
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.05% octenidine in vehicle
Number of subjects: 60

Group type: COMPARATOR
Intervention: vehicle only
Number of subjects: 60
Study: 31353819

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (NSPT) with preparatory 15-day decontamination phase including chlorhexidine mouth rinse and domiciliary hygiene instructions (modified FMD: test group)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-surgical periodontal therapy (NSPT) without preparatory decontamination (FMD: control group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (NSPT) with modified FMD (test group)
Number of subjects: 60
Study: 28632508

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine with transcranial direct current stimulation and speech and language therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo with transcranial direct current stimulation and speech and language therapy
Number of subjects: 10
Study: 26944818

Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 28
Study: 25109699

Group type: EXPERIMENTAL
Intervention: PEG‐IFN treatment for 1 year
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: HLA‐DPB1 polymorphisms
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: HLA‐DPB1 G-allele
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: HLA‐DPA1 and HLA‐DPB1 haplotype block GG
Number of subjects: 262
Study: 21999662

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1200 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 19218296

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study: 16803911

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 1 mug.kg(‐1) iv during induction, continuous infusion at 0.5 mug.kg(‐1).hr(‐1))
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (0.9% saline, volume-matched bolus and infusion)
Number of subjects: 50
Study: 12705367

Group type: EXPERIMENTAL
Intervention: Neonatal sepsis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no sepsis)
Number of subjects: 24